S33005

S33005
Systematic (IUPAC) name
1-[7-[(dimethylamino)methyl]-4-methoxy-7-bicyclo[4.2.0]octa-1(6),2, 4-trienyl]cyclohexan-1-ol
Identifiers
Synonyms (–)-1-(1-dimethylaminomethyl) 5-methoxybenzocyclobutan-1-yl) cyclohexanol
Chemical data
Formula C18H27NO2
Molar mass 289.41248 g/mol

S33005 is a serotonin–norepinephrine reuptake inhibitor (SNRI) that was under development by Servier for the treatment of depression and related disorders. It is structurally related to venlafaxine but has a more complex molecular structure. It is not known if this compound acts as a sigma agonist, although for venlafaxine, apparently it appears that this is indeed the case.

Synthesis

"The 1-cyano-benzocyclobutenes used as starting material are obtained, for example, by subjecting a β-[orthohalogeno-phenyl]-propionitrile to intramolecular condensation in the presence of potassium amide, or by brominating a benzocyclobutene in position 1 with N-bromosuccinimide, followed by exchange of the bromine atom for a cyano group by means of sodium cyanide."[1]

References

External links

This article is issued from Wikipedia - version of the Friday, April 11, 2014. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.